Study explores cancer treatment

A novel, collaborative study beginning at the University of Minnesota in a few months will further explore the method of tailoring drugs to specific patients…

A novel, collaborative study beginning at the University of Minnesota in a few months will further explore the method of tailoring drugs to specific patients. Called I-SPY 2, the study will take place at more than 20 locations around the United States and Canada, including Mayo Clinic…

If successful, the framework could be applied to research on other diseases, said Judy Boughey, the study’s lead investigator at Mayo Clinic.

MN Daily, by Tara Bannow, 3/28/2010